SAMANTHA CAO: Open Payments
NPI 1497468953 · BREA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 33 payments from 12 companies in 2025. Trend: 2023 $117 · 2024 $909 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $307 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $171 |
| Amgen Inc. | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $113 |
| Regeneron Healthcare Solutions, Inc. | 4 | $85 |
| GENZYME CORPORATION | 2 | $64 |
| Cycle Pharmaceuticals Inc | 1 | $30 |
| CSL Behring | 1 | $28 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Pharming Healthcare, Inc. | 1 | $24 |
Products named: TEZSPIRE, DUPIXENT, CUVITRU, BREZTRI, Rhapsido, Sajazir, HYQVIA, Haegarda.
Industry payments across CA — which companies pay providers there.
